We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 5,276 results
  1. Older adults and individuals with Parkinson’s disease control posture along suborthogonal directions that deviate from the traditional anteroposterior and mediolateral directions

    A rich and complex temporal structure of variability in postural sway characterizes healthy and adaptable postural control. However,...

    Madhur Mangalam, Damian G. Kelty-Stephen, ... Nick Stergiou in Scientific Reports
    Article Open access 19 February 2024
  2. Autonomic function and motor subtypes in Parkinson’s disease: a multicentre cross-sectional study

    Autonomic symptoms (AS) are critical in Parkinson’s disease (PD). We aimed to determine the relative significance of clinical factors allowing...

    Si-Chun Gu, Rong Shi, ... Qing Ye in Scientific Reports
    Article Open access 04 September 2023
  3. Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease

    Parkinson’s disease involves multiple neurotransmitter systems beyond the classical dopaminergic circuit, but their influence on structural and...

    Ahmed Faraz Khan, Quadri Adewale, ... Yasser Iturria-Medina in Nature Communications
    Article Open access 26 September 2023
  4. Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithms

    Dyskinesias are non preventable abnormal involuntary movements that represent the main challenge of the long term treatment of Parkinson’s disease...

    Denisson Augusto Bastos Leal, Carla Michele Vieira Dias, ... Ivani Brys in Scientific Reports
    Article Open access 16 December 2023
  5. Cervical percutaneous interferential current stimulation improves citric acid cough tests in patients with Parkinson’s disease on medication

    Aspiration pneumonia is the leading cause of death in patients with Parkinson’s disease. The incidence of silent aspiration is high in such patients...

    Masahiro Nakamori, Megumi Toko, ... Hirofumi Maruyama in Scientific Reports
    Article Open access 18 May 2024
  6. Adaptive neighborhood rough set model for hybrid data processing: a case study on Parkinson’s disease behavioral analysis

    Extracting knowledge from hybrid data, comprising both categorical and numerical data, poses significant challenges due to the inherent difficulty in...

    Imran Raza, Muhammad Hasan Jamal, ... Imran Ashraf in Scientific Reports
    Article Open access 01 April 2024
  7. Chronic intracranial recordings in the globus pallidus reveal circadian rhythms in Parkinson’s disease

    Circadian rhythms have been shown in the subthalamic nucleus (STN) in Parkinson’s disease (PD), but only a few studies have focused on the globus...

    Jackson N. Cagle, Tiberio de Araujo, ... Coralie de Hemptinne in Nature Communications
    Article Open access 30 May 2024
  8. Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson’s disease

    Hallucinations are frequent non-motor symptoms in Parkinson’s disease (PD) associated with dementia and higher mortality. Despite their high clinical...

    Louis Albert, Jevita Potheegadoo, ... Olaf Blanke in Nature Communications
    Article Open access 12 March 2024
  9. Pathological pallidal beta activity in Parkinson’s disease is sustained during sleep and associated with sleep disturbance

    Parkinson’s disease (PD) is associated with excessive beta activity in the basal ganglia. Brain sensing implants aim to leverage this biomarker for...

    Zixiao Yin, Ruoyu Ma, ... Jianguo Zhang in Nature Communications
    Article Open access 05 September 2023
  10. A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease

    Sporadic Parkinson’s Disease (sPD) is a progressive neurodegenerative disorder caused by multiple genetic and environmental factors. Mitochondrial...

    Sebastian Schmidt, Constantin Stautner, ... Wolfgang Wurst in Nature Communications
    Article Open access 23 November 2023
  11. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models

    The nuclear receptor, Nurr1, is critical for both the development and maintenance of midbrain dopamine neurons, representing a promising molecular...

    Woori Kim, Mohit Tripathi, ... Kwang-Soo Kim in Nature Communications
    Article Open access 18 July 2023
  12. The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons

    Disrupted glucose metabolism and protein misfolding are key characteristics of age-related neurodegenerative disorders including Parkinson’s disease,...

    Willayat Y. Wani, Friederike Zunke, ... Joseph R. Mazzulli in Nature Communications
    Article Open access 19 June 2024
  13. Neural signatures of indirect pathway activity during subthalamic stimulation in Parkinson’s disease

    Deep brain stimulation (DBS) of the subthalamic nucleus (STN) produces an electrophysiological signature called evoked resonant neural activity...

    Leon A. Steiner, David Crompton, ... Luka Milosevic in Nature Communications
    Article Open access 11 April 2024
  14. Gut microbiota of Parkinson’s disease in an appendectomy cohort: a preliminary study

    In patients with Parkinson’s disease (PD), α-synuclein pathology is thought to spread to the brain via the dorsal motor nucleus of the vagus nerve....

    Keiichi Nakahara, Shunya Nakane, ... Yukio Ando in Scientific Reports
    Article Open access 07 February 2023
  15. Prevalence and characteristics of dry eye disease in Parkinson’s disease: a systematic review and meta-analysis

    We investigated and characterized the prevalence of dry eye disease (DED) in Parkinson’s disease (PD). PubMed and EMBASE databases were searched for...

    Ken Nagino, Jaemyoung Sung, ... Takenori Inomata in Scientific Reports
    Article Open access 01 November 2022
  16. Eye movement function captured via an electronic tablet informs on cognition and disease severity in Parkinson’s disease

    Studying the oculomotor system provides a unique window to assess brain health and function in various clinical populations. Although the use of...

    Nils A. Koch, Patrice Voss, ... Étienne de Villers-Sidani in Scientific Reports
    Article Open access 20 April 2024
  17. Prediction of cognitive decline in Parkinson’s disease (PD) patients with electroencephalography (EEG) connectivity characterized by time-between-phase-crossing (TBPC)

    The aim of the study is to identify the dynamic change pattern of EEG to predict cognitive decline in patients with Parkinson’s disease. Here we...

    Ute Gschwandtner, Guy Bogaarts, ... Peter Fuhr in Scientific Reports
    Article Open access 29 March 2023
  18. Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

    Soluble α-synuclein aggregates varying in size, structure, and morphology have been closely linked to neuronal death in Parkinson’s disease. However,...

    Derya Emin, Yu P. Zhang, ... David Klenerman in Nature Communications
    Article Open access 20 September 2022
  19. High risk of develo** dementia in Parkinson’s disease: a Swedish registry-based study

    Dementia have substantial negative impact on the affected individual, their care partners and society. Persons living with Parkinson’s disease (PwP)...

    Daniel Oudin Åström, Jacob Simonsen, ... Per Odin in Scientific Reports
    Article Open access 06 October 2022
  20. Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson’s disease

    Parkinson’s disease (PD) is a complex neurodegenerative disorder without a cure. The onset of PD symptoms corresponds to 50% loss of midbrain...

    Katarina Mihajlović, Gaia Ceddia, ... Nataša Pržulj in Scientific Reports
    Article Open access 14 May 2024
Did you find what you were looking for? Share feedback.